Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2015 2
2016 4
2017 9
2018 17
2019 25
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

54 results
Results by year
Filters applied: . Clear all
Page 1
Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders
Higgins L, et al. Clin J Am Soc Nephrol 2018. Among authors: Kourelis T. PMID 29848505 Free PMC article.
Monoclonal gammopathy-related kidney lesions included monoclonal Ig-related amyloidosis (n=19; 33%), nonamyloid glomerulopathy (n=20, 35%), and tubulointerstitial nephropathies (n=8; 14%). The most common monoclonal gammopathy-related kidney lesion was monoclonal Ig-related amyloidosis (n=19; 33%) followed by cryoglobulinemic GN (n=13; 28%). ...
Monoclonal gammopathy-related kidney lesions included monoclonal Ig-related amyloidosis (n=19; 33%), nonamyloid glomerulopathy (n=20, …
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.
Muchtar E, et al. Blood 2017 - Clinical Trial. Among authors: Kourelis TV. PMID 28126928 Free PMC article.
In light of major advances in immunoglobulin light chain (AL) amyloidosis, we evaluated the trends in presentation, management, and outcome among 1551 newly diagnosed AL amyloidosis patients seen in our institution from 2000 to 2014. ...Overall, outcomes among patients with AL amyloidosis have improved with earlier diagnosis, higher rates of VGPR, lower early mortality, and improved OS....
In light of major advances in immunoglobulin light chain (AL) amyloidosis, we evaluated the trends in presentation, management, and o …
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience.
Kourelis TV, et al. Mayo Clin Proc 2017. PMID 28483059
OBJECTIVE: To describe treatment types, outcomes, and relapse patterns in patients with localized immunoglobulin light chain amyloidosis (AL(L)). ...
OBJECTIVE: To describe treatment types, outcomes, and relapse patterns in patients with localized immunoglobulin light chain amyloidosis
Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria.
Muchtar E, et al. Leukemia 2018. Among authors: Kourelis TV. PMID 29581546
Newly diagnosed AL amyloidosis patients who had involvement of at least one evaluable organ and documentation of organ response were included. ...Grading the depth of organ response provides additional valuable prognostic information for newly diagnosed AL amyloidosis patients....
Newly diagnosed AL amyloidosis patients who had involvement of at least one evaluable organ and documentation of organ response were …
Improving strategies for the diagnosis of cardiac amyloidosis.
Kourelis TV and Gertz MA. Expert Rev Cardiovasc Ther 2015 - Review. PMID 26174181
Amyloidosis refers to a group of rare but potentially fatal, protein misfolding diseases. The heart is frequently involved in the most common types, that is, immunoglobulin light chain and transthyretin amyloidosis and is the single most important predictor of patient outcomes. ...
Amyloidosis refers to a group of rare but potentially fatal, protein misfolding diseases. The heart is frequently involved in the mos
54 results
Jump to page
Feedback